Recommendations for prevention of HIV transmission in health-care settings

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Superseded

This Document Has Been Replaced By:

Recommendations for prevention of HIV transmission in health-care settings

August 21, 1987
By Centers for Disease Control (U.S.)
Source: MMWR. Morbidity and mortality weekly report. 1987; 36 Suppl 2:1S-18S.

[HTM]

Select to view the document on External site.

This document file type cannot be previewed

English

Details You May Also Like

Details:

Corporate Authors:

Centers for Disease Control (U.S.)
Description:

On October 16, 2009, the Food and Drug Administration (FDA) licensed bivalent human papillomavirus vaccine (HPV2; Cervarix, GlaxoSmithKline) for use in females aged 10 through 25 years. Cervarix is the second human papillomavirus (HPV) vaccine licensed for use in females in the United States. Quadrivalent HPV vaccine (HPV4; Gardasil, Merck & Co, Inc.) was licensed in 2006 for use in females aged 9 through 26 years, and the Advisory Committee on Immunization Practices (ACIP) recommended routine HPV4 vaccination of females aged 11 or 12 years, and catch-up vaccination for females aged 13 through 26 years (1). This report provides updated recommendations for routine and catch-up vaccination of females with either HPV2 or HPV4.
Subjects:

[+]

Acquired Immunodeficiency Syndrome Antibodies, Viral Decontamination Health Manpower HIV HIV Antibodies Housekeeping Humans Laboratories Laundering Medical Waste Occupational Diseases Renal Dialysis Risk Sterilization
Source:

MMWR. Morbidity and mortality weekly report. 1987; 36 Suppl 2:1S-18S.
Pubmed ID:

3112554
Document Type:

Journal Article
Place as Subject:

United States
Collection(s):

Morbidity and Mortality Weekly Report (MMWR) Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
File Type:

No Additional Files

More +

Superseded

Recommendations for prevention of HIV transmission in health-care settings

Details:

Supporting Files

You May Also Like